🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Wow, GLP-1 is changing the history of chronic diseases.

Sometimes the rarity of a disease keeps us away from creating clinical trials, however it should not be so. One solution, the N-of-1 Trials, a good thread with the most relevant literature.

I've been extensively using Vincent Arel-Bundock {modelsummary} R package for both teaching and research and it is a delight. But I'm here to recommend this presentation of {marginaleffects}, a beautiful approach to interpreting model estimates: youtube.com/watch?v=ANDC_k…

[PAQUETE 📦] - Si sos fan de armar presentaciones en R con {xaringan}, tenes que pasar a visitar al paquete {renderthis}, con quien vas a poder exportar tu trabajo a pdf, html, pptx y más! 🌐 jhelvy.github.io/renderthis/ ✍🏼 John | garrick aden-buie #RStats #RStatsES #Rtips

Check the research briefing of our recent paper in Nature Aging that described the association between the planetary health diet and cognitive decline in #ELSABrasil. Kudos to the brilliant Natalia Goncalves! nature.com/articles/s4358….

In this study, the authors investigated whether neuropathologic processes contribute to brain regional topologic properties of integration and segregation and brain network resilience in #ParkinsonDisease: bit.ly/3WuQBD1 #NeuroTwitter

With deep sorrow, we bid farewell to Dr. Lopera, a visionary researcher and cherished friend. As a founder of our consortium, his pioneering work in Alzheimer's research, has left an indelible mark. His passion, and brilliance will forever inspire us. Rest in peace, Francisco.

Follow the link to support!

Check out our new paper published today The Lancet Global Health where we calculated the potential for dementia prevention in 7 countries of Latin America. Kudos to Regina Paradela Gill Livingston Ismael Calandri Cleusa Ferri Lucía Crivelli Naaheed Mukadam sciencedirect.com/science/articl…

Proud of Florentina presentingnin in the International Society for Frontotemporal Dementias meeting the work of our PPA group in Fleni Ricardo F. Allegri

And that marks the first day of #ISFTD24! With an incredible musical opening, including a heartfelt speech by Emma Heming Willis, a day full of knowledge sharing was kicked off. Excited for tomorrow! Read all about this morning’s opening ceremony here: alzheimercentrum.nl/aftrap-interna…

My highlight from the International Society for Frontotemporal Dementias meeting:the photography contest winner. A powerful image showing how disease turns us into a distorted reflection of who we once were. Both moving and a stark reminder of why we fight every day in this field.Thanks, Sterre de Boer, MD, PhD for organizing this!

Glad that our paper is “trendy”!

Did you know that unlike R, Python indexes at 0? I just found out in the most painful way.

Thank you friends for the countless coffee breaks filled with critical discussions—truly, as they say here, a crucial factor in driving my science forward!

🦂 Te tomás unos minutos, un café y con tu respuesta ayudas a que conozcamos más de arañas y alacranes, y prevengamos picaduras

Naismith's Rule provides a quick estimate for hiking time in the mountains, intended for "easy expeditions." It suggests: --> 1 hour for every 3 miles (5km) walked --> +1 hour for every 2,000 ft (600m) of ascent For example, suppose your hike covers 6 miles with 2,000 ft of

El fileteado artesanal y un esquema de colores que son patrimonio identitario de nuestra ciudad están en peligro... Preservemos la Identidad de Nuestros Colectivos: No al Ploteado - ¡Firmá la petición! chng.it/4kV9zn4fcH

Una excelente oportunidad para quienes busquen formarse en el campo de la neurología cognitiva

Amy Kind, MD, PhD Fermin Travi Christian Limberger Next on #NeuroscienceNext: the Oral Presentation Round! Flavia Saravia presented new findings regarding normoglycemic strategies and microglia's involvement in AD trestment Ismael Calandri then urged us to remember the ever-present gap between trials and real-life implementations